2023
DOI: 10.1080/10408398.2023.2222805
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of bioactive oligosaccharides and their potential health benefits

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 111 publications
0
2
0
Order By: Relevance
“…UV/H 2 O 2 treatment effectively degraded the polysaccharides, resulting in the formation of low molecular weight polysaccharides. This reduction in molecular weight potentially improved their bioavailability, solubility, and cellular uptake, enhancing their interaction with target cells and increasing their bioactivity [ 50 , 51 ]. Besides, UV/H 2 O 2 treatment did not significantly alter the functional groups in DSFPs, ensuring that the essential chemical structures responsible for their biological effects remained intact.…”
Section: Resultsmentioning
confidence: 99%
“…UV/H 2 O 2 treatment effectively degraded the polysaccharides, resulting in the formation of low molecular weight polysaccharides. This reduction in molecular weight potentially improved their bioavailability, solubility, and cellular uptake, enhancing their interaction with target cells and increasing their bioactivity [ 50 , 51 ]. Besides, UV/H 2 O 2 treatment did not significantly alter the functional groups in DSFPs, ensuring that the essential chemical structures responsible for their biological effects remained intact.…”
Section: Resultsmentioning
confidence: 99%
“…The MOs have an enormous molecular weight that cannot be directly utilized by cell, but can be catabolized by gut microbiota, then producing SCFAs to respond to various life activities, such as immune regulation and glucose homeostasis ( Zhu et al, 2020 ; Zhang et al, 2021 ; Chen et al, 2023 ). SCFAs are the main products of prebiotic fermentation, and the production of these metabolites depends on both dietary fiber types and gut microbiota composition ( Bridgman et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…This process highlights A. muciniphila's critical role in shaping the gut microbiota of neonatal piglets, underscoring its evolutionary adaptability and ecological significance, similar to its beneficial functions in human infants. The MOs have an enormous molecular weight that cannot be directly utilized by cell, but can be catabolized by gut microbiota, then producing SCFAs to respond to various life activities, such as immune regulation and glucose homeostasis (Zhu et al, 2020;Zhang et al, 2021;Chen et al, 2023). SCFAs are the main products of prebiotic fermentation, and the production of these metabolites depends on both dietary fiber types and gut microbiota composition (Bridgman et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…These glycosyltransferases are constantly identified from different microorganisms such as WbsJ (encoding α1–2-fucosyltransferase from Escherichia coli O128:B12), and SAMT (encoding α1–2-fucosyltransferase from Azospirillum lipoferum ). Moreover, these lactose-core HMOs can be synthesized in engineered bacteria by introducing glycosyltransferases into GDP-fucose or CMP-Neu5Ac pathway . Lacto- N -triose II (LNTri II, GlcNAcβ1–3Galβ1–4Glc) is the core of more complex HMO derivatives and the direct precursors of lacto- N -tetraose (LNT) and lacto- N -neotetraose (LNnT), and LNT (Galβ1–3GlcNAcβ1–3Galβ1–4Glc) and LNnT (Galβ1–4GlcNAcβ1–3Galβ1–4Glc) can be synthesized by overexpressing β1,3/4-galactosyltransferase genes in engineered bacteria .…”
Section: Structural Categories and Synthesis Of Hmosmentioning
confidence: 99%